Últimas noticias sobre aTyr Pharma (NASDAQ:ATYR) Bolsa

aTyr Pharma

aTyr Pharma Inc is a biotherapeutics company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase platform. The company has concentrated its research and development efforts on a newly discovered area of biology, the extracellular functionality and signaling pathways of tRNA synthetases. Its primary focus is efzofitimod, a clinical-stage product candidate which targets NRP2 to resolve chronic inflammation that can lead to fibrosis. Efzofitimod has a novel mechanism of action for potentially treating lung inflammation and fibrosis.

aTyr Pharma Inc

HC Wainwright &amp; Co. analyst Heiko Ihle maintains Americas Gold And Silver (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/USAS#AMEX">USAS</a>) with a Buy and lowers the price target from $1 to $0.9.

News

Price Target

Analyst Ratings

USAS

HC Wainwright & Co. Maintains Buy on Americas Gold And Silver, Lowers Price Target to $0.9

HC Wainwright &amp; Co. analyst Heiko Ihle maintains enCore Energy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EU#NASDAQ">EU</a>) with a Buy and lowers the price target from $7 to $2.75.

HC Wainwright & Co. Maintains Buy on enCore Energy, Lowers Price Target to $2.75

General

UUUU

Chemours Partners With Energy Fuels  To Form A Domestic Supply Chain Of Critical Minerals For US

U.S. stock futures were flat on Tuesday after a bounce back on Monday. Futures of all four benchmark indices were mixed in premarket trading.
On Monday, stocks continued their recovery from last week&#8217;s sell-off, which had pushed the S&amp;P 500 into correction territory amid growing concerns over the U.S. economy&#8217;s ability to withstand President Donald Trump&#8216;s trade war.
The two-day meeting of the Federal Open Market Committee will begin today as they discuss and announce their decision on interest rates slated to be released tomorrow. Chairman Jerome Powell will address a press conference on Wednesday afternoon.
The 10-year Treasury yield stood at 4.31%, while the two-year yield was at 4.04%. According <a href="https://www.cmegroup.com/markets/interest-rates/cme-fedwatch-tool.html">to</a> the CME Group's FedWatch tool, there is a 99% chance that the Federal Reserve will keep interest rates unchanged tomorrow.
<figure class="wp-block-table is-style-stripes"> 
<table>
<tbody>
<tr>
<td>Futures</td>
<td>Change (+/-)</td>
</tr>
<tr>
<td>Nasdaq 100</td>
<td>-0.21%</td>
</tr>
<tr>
<td>S&amp;P 500</td>
<td>-0.06%</td>
</tr>
<tr>
<td>Dow Jones</td>
<td>0.02%</td>
</tr>
<tr>
<td>Russell 2000</td>
<td>-0.22%</td>
</tr>
</tbody>
</table>
</figure>
The SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) and Invesco QQQ Trust ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>), which tracks the S&amp;P 500 index and Nasdaq 100 index, respectively, dropped slightly in premarket on Monday. The SPY was down 0.15% to $566.37, and the QQQ also declined 0.25% to $481.54, according to <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a> data.
Cues From The Last Session
Real estate, energy, and consumer staples stocks led Monday&#8217;s market rally, with significant gains across the S&amp;P 500. Conversely, consumer discretionary stocks dipped.
This sector-driven strength propelled the Dow Jones higher extending the market&#8217;s recovery after last week&#8217;s sharp declines, which saw the Dow lose 3.1% and the S&amp;P 500 drop over 2%.
In company news, Guess? Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GES#NYSE">GES</a>) shares surged 30% on acquisition interest, and Baidu Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BIDU#NASDAQ">BIDU</a>) shares climbed 9% following the launch of new AI models.
Economic data presented a mixed picture, with retail sales growth below expectations, a sharp drop in the NY Empire State Manufacturing Index, and a decline in housing market confidence.
<figure class="wp-block-table is-style-stripes"> 
<table>
<tbody>
<tr>
<td>Index</td>
<td>Performance (+/-)</td>
<td>Value</td>
</tr>
<tr>
<td>Nasdaq Composite</td>
<td>0.31%</td>
<td>17,808.66</td>
</tr>
<tr>
<td>S&amp;P 500</td>
<td>0.64%</td>
<td>5,675.12</td>
</tr>
<tr>
<td>Dow Jones</td>
<td>0.85%</td>
<td>41,841.63</td>
</tr>
<tr>
<td>Russell 2000</td>
<td>1.19%</td>
<td>2,068.33</td>
</tr>
</tbody>
</table>
</figure>
Insights From Analysts
The market sentiment seemed to be recovering on Monday after the S&amp;P 500 index recorded an upmove in 90% of its issues for two consecutive days. Ryan Detrick of Carson Research highlighted that this was a rare occurrence when 90% of S&amp;P 500 constituents rose back-to-back for two days.
According to the historical data shared by him, this has only happened 12 times since 1972 and the index has been higher in all instances after a year.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Back-to-back 90% advancing issues for the S&amp;P 500. Using <a href="https://twitter.com/NDR_Research?ref_src=twsrc%5Etfw">@NDR_Research</a> data back to 1972 shows higher six and 12 months later every single time, with much better than average returns. I&#39;m sure this will make everyone mad, but it made me &#x1f603; <a href="https://t.co/QWf8lJx2eQ">pic.twitter.com/QWf8lJx2eQ</a>
&mdash; Ryan Detrick, CMT (@RyanDetrick) <a href="https://twitter.com/RyanDetrick/status/1901824344839336317?ref_src=twsrc%5Etfw">March 18, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Meanwhile, Liz Ann Sonders and Kevin Gordon of Charles Schwab said in a note "The only thing we can be certain of is that things will remain uncertain for the time being."
They quoted the data from a few years ago when confidence metrics went through a soft patch giving a &#8220;false&#8221; recessionary signal amid strong underlying growth and the hard data. They termed it as a &#8220;vibecession.&#8221;
Whereas they termed the current period as &#8220;vibespansion," which was evident a few months ago, however, many strong sentiment metrics are receding. "If the soft data stay soft long enough, we see more risk of the hard data catching down," the note added.
Edward Yardeni or Yardeni Research highlighted that the markets could have bottomed out on Thursday last week and rose on Friday and Monday because there was no comment from Trump on tariffs.
He said, "From a sentiment perspective, it is possible that Thursday's selloff followed by Friday's rally marked a bottom in the correction. We will be more inclined to call a bottom when we see the stock market move higher on a day or days when Trump blusters about tariffs again, which he did not do on Friday."
"Any day without a Trump tariff comment is a good day for the market. We know that on April 2 there will be lots of reciprocal tariffs imposed on many more nations by the administration, undoubtedly eliciting lots of comments from Tariff Man," he added.
See Also: <a href="https://www.benzinga.com/money/how-to-trade-futures">How to Trade Futures </a>
Upcoming Economic Data
Here&#8217;s what investors will keep an eye on Tuesday:
<ul>
<li>February&#8217;s housing starts, building permits, and import price index data will be announced at 8:30 a.m., ET.</li>
</ul>
<ul>
<li>Also, February&#8217;s industrial production and capacity utilization data will be released at 9:15 a.m., ET.</li>
</ul>
Stocks In Focus:
<ul>
<li>IHS Holding Ltd. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IHS#NYSE">IHS</a>) was up 0.77% in premarket on Tuesday ahead of its earnings before the opening bell. Analysts expect earnings of 4 cents per share on revenue of $424.00 million.</li>
</ul>
<ul>
<li>HealthEquity Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HQY#NASDAQ">HQY</a>) advanced 0.28% as Wall Street expects it to report earnings of 72 cents per share on revenue of $306.05 million after the closing bell.</li>
</ul>
<ul>
<li>StoneCo Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STN#NASDAQ">STN</a>) rose 0.49% ahead of its earnings after the closing bell. Analysts expect earnings of 35 cents per share on revenue of $647.56 million.</li>
</ul>
<ul>
<li>Getty Images Holdings Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GETY#NYSE">GETY</a>) jumped 2.33% after posting an upbeat earnings result for its fourth quarter on Monday.</li>
</ul>
<ul>
<li>Sangamo Therapeutics Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SGMO#NASDAQ">SGMO</a>) dropped 6.83% after reporting worse-than-expected fourth-quarter financial results.</li>
</ul>
<ul>
<li>Baidu Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BIDU#NASDAQ">BIDU</a>) was 4.39% higher continuing the momentum from yesterday following the launch of new AI models.</li>
</ul>
<ul>
<li>Bon Natural Life Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BON#NASDAQ">BON</a>) surged 29.71% after it secured $12 million in gross proceeds from a best efforts unit offering.</li>
</ul>
<ul>
<li>Harrow Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HROW#NASDAQ">HROW</a>) zoomed 24.14% after it projected 2025 revenue of over $280 million, driven by branded products.</li>
</ul>
<ul>
<li>Bakkt Holdings Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BKKT#NYSE">BKKT</a>) plunged 30.24% after it rescheduled its fourth-quarter earnings call to March 18, 2025.</li>
</ul>
Commodities, Gold And Global Equity Markets:
Crude oil futures were trading higher in the early New York session by 1.35% to hover around $68.28 per barrel.
The gold spot index was up by 0.70% to $3,022.11 per ounce. Its last record high was at $3,028.49 per ounce. The Dollar Index was down by 0.05% at the 103.322 level.
Asian markets closed higher on Tuesday with China&#8217;s CSI 300, Japan's Nikkei 225, South Korea's Kospi, Australia's ASX 200, Hong Kong's Hang Seng, and India's S&amp;P BSE Sensex advancing in trade. European markets were also higher in trade.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/markets/equities/25/03/44371661/ai-bubble-bursting-magnificent-7s-profit-margins-face-pressure-as-capital-spending-can-tumble-in">AI Bubble Bursting? Magnificent 7&#8217;s Profit Margins Face Pressure As &#8216;Capital Spending Can Tumble&#8217; In 2025</a></li>
</ul>
Photo courtesy: Shutterstock

Equities

Market Summary

Futures

Economics

Federal Reserve

Pre-Market Outlook

Markets

BIDU

Bakkt Holdings, Inc. Class A Common Stock

BKKT

GETY

HROW

SGMO

US Futures Show Caution Among Investors Ahead Of FOMC Meeting: Analysts Say Only Certainty Is That 'Things Will Remain Uncertain For The Time Being'

HC Wainwright &amp; Co. analyst Heiko Ihle reiterates First Mining Gold (TSX:<a class="ticker" href="https://www.benzinga.com/stock/FF#TSX">FF</a>) with a Buy and maintains C$0.35 price target.

Reiteration

TSX:FF

HC Wainwright & Co. Reiterates Buy on First Mining Gold, Maintains C$0.35 Price Target

FinVolution Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FINV#NYSE">FINV</a>) shares are trading higher premarket on Tuesday. On Monday, the company reported fourth-quarter&nbsp;revenue of CNY3.46 billion&nbsp;($473.6 million)&nbsp;vs. <a target="_blank" href="https://www.benzinga.com/pressreleases/25/03/n44366998/finvolution-group-reports-fourth-quarter-and-fiscal-year-2024-unaudited-financial-results" rel="noreferrer noopener">CNY3.22 billion a year ago quarter</a>.
Revenues were led by higher loan facilitation service fees and other revenue.
As of December 31, 2024, cumulative registered users rose 45.1% year-over-year (Y/Y) to 35.7 million, and cumulative borrowers in the international market upped 45.8% Y/Y to 7.0 million.
Transaction volume&nbsp;stood at&nbsp;CNY52.4&nbsp;billion, up 8.6% Y/Y, with an increase of 7.8% in China&#8217;s Mainland and 26.1% in the International segment.
Adjusted operating income rose to CNY822.0&nbsp;million ($112.6&nbsp;million)&nbsp;from&nbsp;CNY547.0 million in the prior year quarter.
Adjusted EPS&nbsp;surged to CNY2.74&nbsp;($0.38)&nbsp;from&nbsp;<a target="_blank" href="https://www.benzinga.com/earnings" rel="noreferrer noopener">CNY2.04&nbsp;in the prior year quarter</a>.
As of&nbsp;December 31, 2024, the company had cash and cash equivalents of&nbsp;CNY4.67 billion&nbsp;($640.2 million) and short-term investments, mainly in wealth management products and term deposits, of&nbsp;RMB2,832.4 million&nbsp;($388.0 million).
Jiayuan Xu, Chief Financial Officer, said, &#8220;As part of our&nbsp;unwavering&nbsp;commitment to delivering&nbsp;value to shareholders through&nbsp;business growth and&nbsp;capital return, we deployed approximately&nbsp;US$160.4 million&nbsp;in 2024. This compromised,&nbsp;US$90.2&nbsp;million&nbsp;for share repurchases and&nbsp;US$70.2 million for dividend distributions, representing a total payout ratio of approximately 49.1%.&#8221;
Dividend: The board of directors approved a cash dividend of&nbsp;$0.277&nbsp;per American Depositary Share, up 17% year-over-year, payable on or around&nbsp;May 7, 2025&nbsp;to shareholders <a target="_blank" href="https://www.benzinga.com/pressreleases/25/03/n44367089/finvolution-group-announces-dividend-increase-to-us-0-277-per-american-depositary-share-up-17-year" rel="noreferrer noopener">of record as of&nbsp;April 16, 2025</a>.
Buyback: FinVolution disclosed a new share repurchase program effective March 20, 2025.
Under this program, the company may buy back up to $150 million worth of shares, including <a target="_blank" href="https://www.benzinga.com/pressreleases/25/03/n44367036/finvolution-group-announces-new-share-repurchase-program-up-to-us-150-million" rel="noreferrer noopener">ADSs, through March 19, 2027</a>.
Outlook: The company expects total revenue of around CNY14.4 billion to CNY15.0 billion in 2025, representing <a target="_blank" href="https://www.benzinga.com/calendars/guidance" rel="noreferrer noopener">growth of about 10.0% to 15.0%</a>.&nbsp;
The company stated that despite ongoing macroeconomic recovery and signs of improvement since early 2024, uncertainties remain in the operating markets. FinVolution remains cautiously optimistic, closely monitoring conditions across Pan-Asian markets.
Going forward, FinVolution targets deriving 50% of its revenue from <a target="_blank" href="https://www.benzinga.com/pressreleases/25/03/n44369675/finvolution-group-reports-strong-growth-and-global-expansion-in-2024" rel="noreferrer noopener">international markets by 2030</a>.
After strong growth in Indonesia and the Philippines, the company is fast-tracking expansion into Pakistan and other markets in 2025.
Price Action: FINV shares are up 12.8% at $10.28 premarket at the last check Tuesday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/general/sports-betting/25/03/44361113/bofa-analyst-highlights-regulatory-clarity-as-key-to-unlocking-potential-of-sports-prediction-market" target="_blank" rel="noreferrer noopener">BofA Analyst Highlights Regulatory Clarity As Key To Unlocking Potential Of Sports Prediction Market</a></li>
</ul>
Image via Shutterstock.

Earnings

Mid Cap

Guidance

Dividends

Buybacks

Movers

FINV

FinVolution Reports Strong Q4, Eyes 50% Revenue From International Markets By 2030 & More

Macro Economic Events

Econ #s

Eurozone ZEW Economic Sentiment For March 39.8 Vs. 43.6 Est.; 24.2 Prior

Eurozone Trade Balance For January 1.0B Vs. 14.0B Est.; 15.4B (Revised) Prior

PODD

Insulet Makes Omnipod 5 Automated Insulin Delivery (AID) System Available In Australia

Germany ZEW Economic Sentiment For March 51.6 Vs. 48.1 Est.; 26.0 Prior

Germany ZEW Current Conditions For March -87.6 Vs. -80.5 Est.; -88.5 Prior

HC Wainwright &amp; Co. analyst Heiko Ihle reiterates Electra Battery Materials (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ELBM#NASDAQ">ELBM</a>) with a Buy and maintains $2.4 price target.

ELBM

HC Wainwright & Co. Reiterates Buy on Electra Battery Materials, Maintains $2.4 Price Target

Business Outlook
For the first quarter of 2025, the Company expects:
<ul>
<li>Deliveries of vehicles to be between 91,000 and 93,000, representing a year-over-year increase of approximately 317.0% to 326.2%. &nbsp;</li>
<li>Total revenues to be between RMB15.0 billion and RMB15.7 billion, representing a year-over-year increase of approximately 129.1% to 139.8%.</li>
</ul>

XPEV

XPeng Expects Q1 Vehicle Deliveries Of 91K-93K, Up By 317%-326.8% YoY, Revenue Of RMB15B-RMB15.7B Vs. RMB14.684B Est.

GLDG

GoldMining Starts Exploration Program At São Jorge Project In Brazil

Operational and Financial Highlights for the Three Months Ended December 31, 2024
<figure class="table"> 
<table>
<tbody>
<tr>
<td>2024Q4</td>
<td>2024Q3</td>
<td>2024Q2</td>
<td>2024Q1</td>
<td>2023Q4</td>
<td>2023Q3</td>
<td>&nbsp;</td>
</tr>
<tr>
<td>Total deliveries</td>
<td>91,507</td>
<td>46,533</td>
<td>30,207</td>
<td>21,821</td>
<td>60,158</td>
<td>40,008</td>
</tr>
</tbody>
</table>
</figure>
<ul>
<li>Total deliveries of vehicles were 91,507 for the fourth quarter of 2024, representing an increase of 52.1% from 60,158 in the corresponding period of 2023. &nbsp;</li>
</ul>

XPeng's Q4 Vehicle Deliveries Surged 52.1% Year-Over-Year To 91,507 Units, While Full-Year Deliveries Climbed 34.2% To 190,068 Vehicles

Offerings

VNET

VNET Closes $430M Convertible Senior Notes Offering Due 2030

Ascendiant Capital analyst Lucas Ward maintains HeartSciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HSCS#NASDAQ">HSCS</a>) with a Buy and lowers the price target from $15 to $14.

HSCS

Ascendiant Capital Maintains Buy on HeartSciences, Lowers Price Target to $14

Contracts

KBR Bags $229M Contract For US Army Cargo Helicopter Systems

On Monday, March 17, U.S. markets closed in green as investors bought beaten-down shares after weeks of losses. Factory activity in New York dropped sharply, and homebuilder sentiment fell due to rising costs from tariffs.
Investors are now focused on the Federal Reserve&#8217;s meeting Wednesday, where interest rates are expected to remain unchanged.
According to economic data, U.S. retail sales rose by 0.2% in February, below the expected 0.6% increase. New York&#8217;s manufacturing index dropped to -20.0, its lowest since May 2023, and homebuilder confidence fell to 39 in March from 42 in February.
Most S&amp;P 500 sectors closed higher on Monday, led by real estate, energy, and consumer staples, while consumer discretionary stocks declined.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
The Dow Jones Industrial Average rose 0.85% to close at 41,841.63, the S&amp;P 500 gained 0.64% to 5,675.12, and the Nasdaq Composite increased 0.31% to 17,808.66.
Asia Markets Today
<ul>
<li>On Tuesday, Japan&#8217;s Nikkei 225 rose 1.24% to 37,859.00, led by gains in the Power, Rubber and Chemical, Petroleum &amp; Plastic sectors.</li>
<li>Australia&#8217;s S&amp;P/ASX 200 was up 0.08% and closed at 7,860.40, led by gains in the Utilities, Gold and A-REITs sectors.</li>
<li>India&#8217;s Nifty 50 rose 1.29% to 22,800.35 and Nifty 500 was up 1.66% at 20,624.05.</li>
<li>China&#8217;s Shanghai Composite declined 0.11% to 3,429.76, and the Shanghai Shenzhen CSI 300 rose 0.27% to 4,007.72.</li>
<li>Hong Kong&#8217;s Hang Seng rallied up 2.46%, ending the session at 24,740.57.</li>
</ul>
Eurozone at 05:45 AM ET
<ul>
<li>The European STOXX 50 was up 0.93%.</li>
<li>Germany&#8217;s DAX gained 1.32%.</li>
<li>France&#8217;s CAC rose 0.64%.</li>
<li>U.K.&#8217;s FTSE 100 index traded higher by 0.50%</li>
</ul>
Commodities at 05:45 AM ET
<ul>
<li>Crude Oil WTI was trading higher by 1.48% at $68.35/bbl, and Brent was up 1.36% at $72.04/bbl.</li>
<li>Oil prices edged up, supported by Middle East tensions and China&#8217;s stimulus plans. However, gains were limited by global growth concerns, U.S. tariffs, and Ukraine ceasefire uncertainty.</li>
<li>Natural Gas declined 0.95% to $3.980.</li>
<li>Gold clocked an all-time high of $3,037. At the time of writing, it was trading higher by 0.82% at $3,030.46, Silver was up 1.32% to $34.763, and Copper rose 0.41% to $4.9795.</li>
</ul>
U.S. Futures at 05:45 AM ET
Dow futures were down 0.02%, S&amp;P 500 futures fell 0.02% and Nasdaq 100 futures declined 0.10%.
Forex at 05:45 AM ET
<ul>
<li>The U.S. dollar index slid 0.08% to 103.33, the USD/JPY rose 0.40% to 149.81, and the USD/AUD rose 0.01% to 1.5664.</li>
<li>The U.S. dollar edged lower Tuesday ahead of the Fed meeting, while the euro rose on Germany&#8217;s stimulus hopes. The yen slipped before the BOJ decision, and China&#8217;s yuan held steady.</li>
</ul>
Photo via Shutterstock

Asia

Eurozone

Commodities

Forex

ADIV

AGOV

ASHR

BBEU

BOIL

CQQQ

PowerShares DBmmodity Index Optimum Yield Diversified Fund

EEMA

FLAX

CurrencyShares British Pound Sterling Trust

IEMG

IEUR

KraneShares Trust KraneShares S&P Pan Asia Dividend Aristocrats Index ETF

KDIV

SPEM

USDU

PowerShares DB US Dollar Index Bullish Fund

Asia And Europe Markets Gains, Gold Makes New High - Global Markets Today While US Slept

Lee Jae-yong, Chairman of Samsung Electronics (OTC:<a class="ticker" href="https://www.benzinga.com/stock/SSNLF#OTC">SSNLF</a>), has urged the company&#8217;s executives to adopt a &#8220;death-defying&#8221; mindset to tackle the challenges posed by the artificial intelligence (AI) era.
What Happened: Lee, in a video message, addressed to around 2,000 executives of Samsung&#8217;s affiliates underscored the need for a strategic shift in the company&#8217;s approach, drawing on the management philosophies of&nbsp;late founding Chairman Lee Byung-chul&nbsp;and former Chairman Lee Kun-hee, as reported by&nbsp;<a href="https://www.koreatimes.co.kr/www/tech/2025/03/129_394287.html">The Korea Times</a>. Lee, however,&nbsp;did not appear in the&nbsp;video himself.
&#8220;Samsung&nbsp;is facing a do-or-die survival&nbsp;issue. We need to reflect&nbsp;deeply from the top,&#8221;&nbsp;Lee reportedly stated in the video. He emphasized the urgency of the situation and the need to invest in the future, even at the cost of immediate profits.
As part of the seminar, executives received a crystal plaque the size of a business card, engraved with the words: &#8220;Samsung&nbsp;people who are strong in&nbsp;crisis, good at reversal and&nbsp;fierce in competition,&#8221; reinforcing the company&#8217;s&nbsp;call for resilience. 
SEE ALSO: <a href="https://www.benzinga.com/general/space/25/03/44370917/nasa-astronauts-sunita-williams-and-butch-willmore-head-back-to-earth-on-spacex-dragon-capsule">NASA Astronauts Sunita Williams And Butch Willmore Head Back To Earth On SpaceX Dragon Capsule</a>
Why It Matters: This call for a strategic shift comes at a crucial time for Samsung. Samsung has&nbsp;been dealing with challenges&nbsp;in the AI semiconductor sector,&nbsp;especially&nbsp;in high bandwidth memory (HBM),&nbsp;where it lags behind its competitor&nbsp;SK Hynix Inc. Simultaneously, the Trump administration&#8217;s aggressive tariffs created uncertainty for Samsung&#8217;s mobile and consumer businesses.
Meanwhile, Chinese news portal Ijiwei reported that Samsung has chosen to suspend future investments in Mexico due to uncertainties surrounding Trump&#8217;s proposed tariffs.
Samsung&#8217;s <a href="https://www.benzinga.com/news/earnings/25/01/43382010/samsung-q4-earnings-12-revenue-growth-closes-gap-with-apple-in-premium-phones-eyes-ai-powered-growth-in-2025" target="_blank" rel="noreferrer noopener">fourth-quarter revenue</a>&nbsp;climbed 12% to 75.8 trillion Korean won ($52.2 billion). However, due to market conditions, operating profit declined by 30% quarter-on-quarter to 6.5 trillion Korean won ($4.48 billion).
Earlier this year,&nbsp;<a href="https://www.benzinga.com/news/management/25/02/43440540/samsungs-jay-y-lee-acquitted-shifting-focus-to-business-challenges">Lee was acquitted</a>&nbsp;of fraud and stock-rigging charges, removing a significant legal obstacle as Samsung navigates business challenges. 
READ MORE:
<ul>
<li><a href="https://www.benzinga.com/personal-finance/25/03/44343816/why-charlie-munger-never-sold-a-single-costco-share-the-billionaire-investor-called-himself-a-total-addict-of-the-store">Why Charlie Munger Never Sold A Single Costco Share—The Billionaire Investor Called Himself A &#8216;Total Addict&#8217; Of The Store</a></li>
</ul>
Image via Shutterstock
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

Tech

SSNLF

Samsung Chairman Urges Execs To Embrace 'Death-Defying' Mindset Amid AI Challenges, Says Company Is 'Facing A Do-Or-Die' Issue

Biotech

Management

Press Releases

aTyr Pharma Announces the Appointment of Eric Benevich to its Board of Directors

aTyr Pharma to Present at the 43rd Annual J.P. Morgan Healthcare Conference

aTyr Pharma to Present Three Posters for Efzofitimod at the American Thoracic Society (ATS) 2025 International Conference

aTyr Pharma to Present at the Leerink Partners Global Healthcare Conference

aTyr Pharma to Webcast Conference Call Reporting Fourth Quarter and Full Year End 2024 Financial Results

Health Care

aTyr Pharma Announces Fourth Positive DSMB Review for Efzofitimod in Phase 3 EFZO-FIT™ Study in Pulmonary Sarcoidosis

aTyr Pharma Announces Publication Demonstrating Efzofitimod's Immunomodulatory Activity in Science Translational Medicine

aTyr Pharma Announces Fourth Quarter and Full Year 2024 Results and Provides Corporate Update

Comments

aTyr Pharma

Noticias

Últimas noticias sobre aTyr Pharma (NASDAQ:ATYR) Bolsa

La gente también mira

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL